Crohn's Disease and Colitis Trial, Recruiting NCT04330846 Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT04330846
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old.
  • People who have Crohn's disease with a newly developed fibrous (scar tissue) narrowing of the intestine, confirmed by both camera examination (colonoscopy) and imaging scans, where the narrowing can be reached by colonoscopy.
  • People who have a known narrowing that was previously treated with a stent or stretching procedure, as long as that treatment was done more than one year before joining the trial.
  • People who have symptoms of a blocked or partially blocked intestine.
  • People whose Crohn's disease has not responded to standard medical treatments.
  • People whose narrowing measures less than 10 cm in length.
  • People with no more than 2 intestinal narrowings.
  • People who have given their written agreement to take part in the trial.

Who may not be able to join:

  • People who have not given their written agreement to take part.
  • People whose narrowing is complicated by an abscess, a fistula (abnormal tunnel between organs), or significant Crohn's disease activity beyond just the area of narrowing.
  • People who had a stent placed or a stretching procedure done on a known narrowing less than one year before the trial start date.
  • People who are pregnant or breastfeeding.
  • People whose health condition makes it unsafe to perform a colonoscopy or surgery.
  • People whose narrowing cannot be reached by colonoscopy.
  • People who have no symptoms related to the narrowing.
  • People whose narrowing is 10 cm or longer.
  • People who have more than 2 intestinal narrowings.
  • People with serious blood clotting problems, specifically a very low platelet count or abnormal clotting test results (confirm with trial site for exact threshold details).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carme Loras, Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Phone: 635 899 553

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Registry
ClinicalTrials.gov
Start date
29 November 2022
Est. completion
1 April 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Quality of life of patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov